Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient

Francesca Caccuri, Elena Muraro, Annunziata Gloghini, Ombretta Turriziani, Mara Riminucci, Cinzia Giagulli, Katy Mastorci, Damiana Antonia Fae', Simona Fiorentini, Antonino Carbone, Arnaldo Caruso, Riccardo Dolcetti

Research output: Contribution to journalArticle

Abstract

Despite antiretroviral therapy, HIV+ individuals still have increased risk to develop lymphomas, including marginal zone lymphomas, suggesting that factors other than HIV-related immunosuppression are probably acting as lymphomagenic factors in the HIV setting. The possible pathogenic involvement of HIV p17 protein variants was investigated in a particularly informative case of HIV-related splenic marginal zone lymphoma, which was negative for oncogenic virus infections, thus allowing us to assess the possible direct contribution of these HIV-encoded proteins to lymphomagenesis. The presence of p17 protein was analyzed by immunohistochemistry in lymphoma tissue. Recombinant p17 protein derived from the dominant sequence detected in plasma and lymphoma biopsy was characterized for B-cell proliferation, clonogenicity in soft agar, in vitro tube formation and wound healing. Intracellular signaling was investigated by immunoblotting. HIV p17 protein was detected in reactive lymphoid follicles but not within lymphoma cells. An identical dominant variant p17 sequence, p17-Lyrm, carrying a 117 to 118 Ala-Ala insertion was detected in both plasma and lymphoma tissue. Recombinant p17-Lyrm enhanced B-cell proliferation and clonogenicity promoted the formation of capillary-like structures and enhanced endothelial cell migration. Unlike reference p17, the p17-Lyrm variant enhanced the activation of Akt and ERK, critical kinases in lymphomagenesis. p17-Lyrm clonogenic activity was dependent on the activation of Akt but not of ERK1/2. These results indicated that HIV p17 variants with distinct molecular signatures and functional properties may accumulate in lymphoid tissues of HIV-infected individuals where they may act as a local stimulus promoting the development of lymphomas.

Original languageEnglish
JournalHematological Oncology
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Lymphoma
HIV
Human Immunodeficiency Virus Proteins
B-Lymphocytes
Cell Proliferation
Oncogenic Viruses
Lymphoid Tissue
Virus Diseases
Recombinant Proteins
Immunoblotting
Wound Healing
Immunosuppression
Agar
Cell Movement
Phosphotransferases
Endothelial Cells
Immunohistochemistry
Biopsy
Proteins

Keywords

  • B lymphocytes
  • HIV
  • lymphomagenesis
  • marginal zone lymphoma
  • p17

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient. / Caccuri, Francesca; Muraro, Elena; Gloghini, Annunziata; Turriziani, Ombretta; Riminucci, Mara; Giagulli, Cinzia; Mastorci, Katy; Fae', Damiana Antonia; Fiorentini, Simona; Carbone, Antonino; Caruso, Arnaldo; Dolcetti, Riccardo.

In: Hematological Oncology, 01.01.2018.

Research output: Contribution to journalArticle

Caccuri, F, Muraro, E, Gloghini, A, Turriziani, O, Riminucci, M, Giagulli, C, Mastorci, K, Fae', DA, Fiorentini, S, Carbone, A, Caruso, A & Dolcetti, R 2018, 'Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient', Hematological Oncology. https://doi.org/10.1002/hon.2562
Caccuri, Francesca ; Muraro, Elena ; Gloghini, Annunziata ; Turriziani, Ombretta ; Riminucci, Mara ; Giagulli, Cinzia ; Mastorci, Katy ; Fae', Damiana Antonia ; Fiorentini, Simona ; Carbone, Antonino ; Caruso, Arnaldo ; Dolcetti, Riccardo. / Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient. In: Hematological Oncology. 2018.
@article{258c3572bfa3430ea181a69290a04f9e,
title = "Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient",
abstract = "Despite antiretroviral therapy, HIV+ individuals still have increased risk to develop lymphomas, including marginal zone lymphomas, suggesting that factors other than HIV-related immunosuppression are probably acting as lymphomagenic factors in the HIV setting. The possible pathogenic involvement of HIV p17 protein variants was investigated in a particularly informative case of HIV-related splenic marginal zone lymphoma, which was negative for oncogenic virus infections, thus allowing us to assess the possible direct contribution of these HIV-encoded proteins to lymphomagenesis. The presence of p17 protein was analyzed by immunohistochemistry in lymphoma tissue. Recombinant p17 protein derived from the dominant sequence detected in plasma and lymphoma biopsy was characterized for B-cell proliferation, clonogenicity in soft agar, in vitro tube formation and wound healing. Intracellular signaling was investigated by immunoblotting. HIV p17 protein was detected in reactive lymphoid follicles but not within lymphoma cells. An identical dominant variant p17 sequence, p17-Lyrm, carrying a 117 to 118 Ala-Ala insertion was detected in both plasma and lymphoma tissue. Recombinant p17-Lyrm enhanced B-cell proliferation and clonogenicity promoted the formation of capillary-like structures and enhanced endothelial cell migration. Unlike reference p17, the p17-Lyrm variant enhanced the activation of Akt and ERK, critical kinases in lymphomagenesis. p17-Lyrm clonogenic activity was dependent on the activation of Akt but not of ERK1/2. These results indicated that HIV p17 variants with distinct molecular signatures and functional properties may accumulate in lymphoid tissues of HIV-infected individuals where they may act as a local stimulus promoting the development of lymphomas.",
keywords = "B lymphocytes, HIV, lymphomagenesis, marginal zone lymphoma, p17",
author = "Francesca Caccuri and Elena Muraro and Annunziata Gloghini and Ombretta Turriziani and Mara Riminucci and Cinzia Giagulli and Katy Mastorci and Fae', {Damiana Antonia} and Simona Fiorentini and Antonino Carbone and Arnaldo Caruso and Riccardo Dolcetti",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/hon.2562",
language = "English",
journal = "Hematological Oncology",
issn = "0278-0232",
publisher = "wiley",

}

TY - JOUR

T1 - Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient

AU - Caccuri, Francesca

AU - Muraro, Elena

AU - Gloghini, Annunziata

AU - Turriziani, Ombretta

AU - Riminucci, Mara

AU - Giagulli, Cinzia

AU - Mastorci, Katy

AU - Fae', Damiana Antonia

AU - Fiorentini, Simona

AU - Carbone, Antonino

AU - Caruso, Arnaldo

AU - Dolcetti, Riccardo

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Despite antiretroviral therapy, HIV+ individuals still have increased risk to develop lymphomas, including marginal zone lymphomas, suggesting that factors other than HIV-related immunosuppression are probably acting as lymphomagenic factors in the HIV setting. The possible pathogenic involvement of HIV p17 protein variants was investigated in a particularly informative case of HIV-related splenic marginal zone lymphoma, which was negative for oncogenic virus infections, thus allowing us to assess the possible direct contribution of these HIV-encoded proteins to lymphomagenesis. The presence of p17 protein was analyzed by immunohistochemistry in lymphoma tissue. Recombinant p17 protein derived from the dominant sequence detected in plasma and lymphoma biopsy was characterized for B-cell proliferation, clonogenicity in soft agar, in vitro tube formation and wound healing. Intracellular signaling was investigated by immunoblotting. HIV p17 protein was detected in reactive lymphoid follicles but not within lymphoma cells. An identical dominant variant p17 sequence, p17-Lyrm, carrying a 117 to 118 Ala-Ala insertion was detected in both plasma and lymphoma tissue. Recombinant p17-Lyrm enhanced B-cell proliferation and clonogenicity promoted the formation of capillary-like structures and enhanced endothelial cell migration. Unlike reference p17, the p17-Lyrm variant enhanced the activation of Akt and ERK, critical kinases in lymphomagenesis. p17-Lyrm clonogenic activity was dependent on the activation of Akt but not of ERK1/2. These results indicated that HIV p17 variants with distinct molecular signatures and functional properties may accumulate in lymphoid tissues of HIV-infected individuals where they may act as a local stimulus promoting the development of lymphomas.

AB - Despite antiretroviral therapy, HIV+ individuals still have increased risk to develop lymphomas, including marginal zone lymphomas, suggesting that factors other than HIV-related immunosuppression are probably acting as lymphomagenic factors in the HIV setting. The possible pathogenic involvement of HIV p17 protein variants was investigated in a particularly informative case of HIV-related splenic marginal zone lymphoma, which was negative for oncogenic virus infections, thus allowing us to assess the possible direct contribution of these HIV-encoded proteins to lymphomagenesis. The presence of p17 protein was analyzed by immunohistochemistry in lymphoma tissue. Recombinant p17 protein derived from the dominant sequence detected in plasma and lymphoma biopsy was characterized for B-cell proliferation, clonogenicity in soft agar, in vitro tube formation and wound healing. Intracellular signaling was investigated by immunoblotting. HIV p17 protein was detected in reactive lymphoid follicles but not within lymphoma cells. An identical dominant variant p17 sequence, p17-Lyrm, carrying a 117 to 118 Ala-Ala insertion was detected in both plasma and lymphoma tissue. Recombinant p17-Lyrm enhanced B-cell proliferation and clonogenicity promoted the formation of capillary-like structures and enhanced endothelial cell migration. Unlike reference p17, the p17-Lyrm variant enhanced the activation of Akt and ERK, critical kinases in lymphomagenesis. p17-Lyrm clonogenic activity was dependent on the activation of Akt but not of ERK1/2. These results indicated that HIV p17 variants with distinct molecular signatures and functional properties may accumulate in lymphoid tissues of HIV-infected individuals where they may act as a local stimulus promoting the development of lymphomas.

KW - B lymphocytes

KW - HIV

KW - lymphomagenesis

KW - marginal zone lymphoma

KW - p17

UR - http://www.scopus.com/inward/record.url?scp=85056107887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056107887&partnerID=8YFLogxK

U2 - 10.1002/hon.2562

DO - 10.1002/hon.2562

M3 - Article

JO - Hematological Oncology

JF - Hematological Oncology

SN - 0278-0232

ER -